Comparison between dexmedetomidine and propofol on duration of stay and suitability of discharge from PACU after short surgeries

A prospective randomized comparison between dexmedetomidine and propofol on the length of stay and recovery profile at post anesthesia care unit for short duration surgical procedures - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063522

Enrollment

Registered

2024-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R938- Abnormal findings on diagnostic imaging of other specified body structures

Interventions

Intervention1: Dexmedetomidine and propofol: Not applicable Intervention2: Dexmedetomidine: Dexmedetomidine is a sedative drugs..will be given to one group at 0.5 microgram/kg/hour as IV infusion Cont

Eligibility

Inclusion criteria

Inclusion criteria: ASA status I and II, undergoing short duration surgeries

Exclusion criteria

Exclusion criteria: Pregnant patients, ASA grade more than II and having major comorbidities

Design outcomes

Primary

Measure	Time frame
Checking whether patients given dexmedetomidine or propofol have a shorter length of stay in PACUTimepoint: All will be assessed at baseline and subsequently at every 10 minute intervals	—

Secondary

Measure	Time frame
To determine any incidence of hypotension, hypertension, bradycardia, tachycardia, hypoxiaTimepoint: All will be assessed at baseline & subsequently at 10 minute intervals	—

Countries

India

Contacts

Public ContactSumodhur Mukherjee

RG Kar Medical College and hospital, Kolkata

agamoni_bhat@rediffmail.com9830438434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026